Trichomonas vaginalis (TMA)
Use
The APTIMA Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test cleared by the FDA for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis. This assay helps in diagnosing trichomoniasis, a sexually transmitted infection that can cause various symptoms and complications if untreated. The test is particularly relevant for sexual health screening in populations at risk.
Special Instructions
Urine in preservative-free urine collection cup: Void the first 10mL to reduce potential contamination. It's crucial to follow specific collection and storage instructions to maintain sample integrity.
Limitations
Stated turn-around-times are for clinical use only and are subject to change based on biopharma protocol requirements. The final turn-around times will be specified in the biopharma study contract. Results should be interpreted in the context of clinical symptoms and other diagnostic results, as diagnosis may not always correlate directly with symptoms or resolve after treatment.
FDA Approved
Methodology
PCR-based (TMA)
Biomarkers
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Cervical Swab
Volume
3mL
Minimum Volume
Not provided
Container
ThinPrep® or SurePath™
Storage Instructions
2°C to 25°C
Causes for Rejection
Insufficient specimen volume
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 21 Days |